Ankylose This! Living with Ankylosing Spondylitis

Tuesday, April 14, 2009

Golimumab approved in Canada

I'm trying my best to step back a bit from the steady stream of news coming in about TNF-alpha blockers (i.e., biologics), because it can drown out everything else about our disease. But I have a selfish interest in the news that golimumab, which now has the trade name of Simponi, has been approved in Canada for the treatment of rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis; it's apparently to be used in combination with methotrexate, and, like other biologics, it's indicated for AS when conventional (i.e., affordable) therapies have failed.

Previously: Golimumab and ankylosing spondylitis.

Labels: , , ,


 
江西快3预测 宝博棋牌唯一官网 fg美人捕鱼彩金 润和软件股票 捉鸡麻将贵阳 棋牌捕鱼王 下载大众麻将免费安装 网上如何写文章赚钱 互联网是怎么赚钱的 福建体育31选7推荐号 码组什么意思